XML 25 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1
Note 8 - Accrued Liabilities
6 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Accrued Liabilities [Text Block]

Note 8 - Accrued Liabilities

 

Accrued liabilities consist of the following:

 

   

December 31,

   

June 30,

 
   

2023

   

2023

 
   

(in thousands)

 

Accrued savings offers

  $ 14,852     $ 15,739  

Accrued program liabilities

    11,841       11,012  

Accrued customer and product related fees

    5,699       6,579  

Return reserve

    5,129       5,777  

Accrued employee compensation

    3,362       5,675  

Other accrued liabilities

    2,530       2,017  

Total accrued liabilities

  $ 43,413     $ 46,799  

 

Accrued savings offers represent programs for the Company’s patients covered under commercial payor plans in which the cost of a prescription to such patients is discounted. Accrued program liabilities include government and commercial rebates. Accrued employee compensation includes sales commissions, paid time off earned, accrued payroll and accrued bonus. Accrued customer and product related fees include accrued expenses and deductions for rebates, wholesaler chargebacks and fees, and other product-related fees and deductions such as royalties for Pediatric Portfolio products, accrued distributor fees, and Medicaid liabilities. The return reserve represents the Company’s accrual for estimated product returns. Other accrued liabilities consist of various other accruals, none of which individually or in the aggregate represent greater than five percent of total liabilities.